Möchten Sie immer auf dem neuesten Stand bleiben?

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED...

Q4-25 Revenue of € 166.4 Million and Net Income of € 42.8 Million Up 25.4% and 69.2%, Respectively, vs Q3-25. Orders of € 250.4 Million Up 43.3% vs. Q3-25 and 105.4% vs. Q4-24FY-25 Revenue of € 591.3...

All amounts are in United States dollars, unless otherwise stated. TORONTO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today reported its...

Allied Gold provides Q4 2025 operating results and 2026 guidance

HAMILTON, Bermuda, Feb. 18, 2026 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE:SPNT) today announced results for its fourth quarter ended December 31, 2025 Fourth...

Press releaseParis, 18 February 2026 Financial information at 31 December 2025 Success of Lead the Future 2023-2025 strategic plan; 2025 objectives fully achieved Orange delivered very solid...

NEW PORT RICHEY, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” or the “Company”), a provider of residential solar and commercial long-duration energy-storage...

PARIS, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) ("Constellium" or the "Company") today reported results for the fourth quarter and the full year ended December 31, 2025. Fourth...

WEST ORANGE, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Bel Fuse Inc. (Nasdaq: BELFA and BELFB) today announced preliminary financial results for the fourth quarter and full year of 2025. Fourth...

$107.1 million in 4Q VYJUVEK revenue and $730.3 million since U.S. launch FDA granted RMAT to KB707 for the treatment of advanced NSCLC and Fast Track Designation to KB111 for the treatment of HHD ...